Pure Global
NCT06401928

Electrical Brain Stimulation for Treatment of Secondary Symptoms in Multiple Sclerosis

Electrical Brain Stimulation for Improving Mental Health and Cognitive Functioning in Patients With Multiple Sclerosis
The National Brain Mapping Laboratory (NBML)·ClinicalTrials.gov·device·Device trialCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Multiple Sclerosis
Drug/Device/Intervention
transcranial direct current stimulation
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
The National Brain Mapping Laboratory (NBML)
Location
Rasht, Iran
Timeline & enrollment
Phase
N/A
Start date
Feb 28, 2023
End date
Jan 31, 2024
Enrollment
53 participants
Primary outcome

Multiple Sclerosis Impact Scale (MSIS-29),and Depression Anxiety Stress Scale-21 (DASS-21),Mini sleep questionnaire (MSQ)

Summary

Multiple Sclerosis (MS) is an autoimmune disease associated with physical disability,
 psychological impairment, and cognitive dysfunction. As a result, the disease burden is high,
 and treatment options are limited. In this randomized, double-blind study, the investigators
 planned to use repeated electrical stimulation and assess mental health-related variables
 (e.g., quality of life, sleep, psychological distress) and cognitive dysfunction in patients
 with MS.

ICD-10 classifications
Multiple sclerosisProgressive systemic sclerosisSystemic sclerosisSystemic sclerosis, unspecifiedDiffuse sclerosis
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06401928
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06401928 through Pure Global AI's free database. This phase not specified trial is sponsored by The National Brain Mapping Laboratory (NBML) and is currently Completed. The study focuses on Multiple Sclerosis. Target enrollment is 53 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.